Diverse effects on mitochondrial and nuclear functions elicited by drugs and genetic knockdowns in bloodstream stage Trypanosoma brucei.
BACKGROUND
The options for treating the fatal disease human African trypanosomiasis are limited to a few drugs that are toxic or facing increasing resistance. New drugs that kill the causative agents, subspecies of Trypanosoma brucei, are therefore urgently needed. Little is known about the cellular mechanisms that lead to death of the pathogenic bloodstream stage.


RESULTS
We therefore conducted the first side by side comparison of the cellular effects of multiple death inducers that target different systems in bloodstream form parasites, including six drugs (pentamidine, prostaglandin D(2), quercetin, etoposide, camptothecin, and a tetrahydroquinoline) and six RNAi knockdowns that target distinct cellular functions. All compounds tested were static at low concentrations and killed at high concentrations. Dead parasites were rapidly quantified by forward and side scatter during flow cytometry, as confirmed by ethidium homodimer and esterase staining, making these assays convenient for quantitating parasite death. The various treatments yielded different combinations of defects in mitochondrial potential, reactive oxygen species, cell cycle, and genome segregation. No evidence was seen for phosphatidylserine exposure, a marker of apoptosis. Reduction in ATP levels lagged behind decreases in live cell number. Even when the impact on growth was similar at 24 hours, drug-treated cells showed dramatic differences in their ability to further proliferate, demonstrating differences in the reversibility of effects induced by the diverse compounds.


CONCLUSIONS
Parasites showed different phenotypes depending on the treatment, but none of them were clear predictors of whether apparently live cells could go on to proliferate after drugs were removed. We therefore suggest that clonal proliferation assays may be a useful step in selecting anti-trypanosomal compounds for further development. Elucidating the genetic or biochemical events initiated by the compounds with the most profound effects on subsequent proliferation may identify new means to activate death pathways.
Worthen
Christal
C
Seattle Biomedical Research Institute, Seattle, Washington, USA.
Jensen
Bryan C
BC
Parsons
Marilyn
M
D000255:Adenosine Triphosphate / Q000378:metabolism; D000981:Antiprotozoal Agents / Q000494:pharmacology*; D017209:Apoptosis; D002453:Cell Cycle / Q000187:drug effects; D002467:Cell Nucleus / Q000187:drug effects*; D020090:Chromosome Segregation / Q000187:drug effects; D004353:Drug Evaluation, Preclinical / Q000379:methods; D055785:Gene Knockdown Techniques; D053078:Membrane Potential, Mitochondrial / Q000187:drug effects; D050296:Microbial Viability / Q000187:drug effects; D008928:Mitochondria / Q000187:drug effects*; D010274:Parasitology / Q000379:methods; D034741:RNA, Small Interfering / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism; D013194:Staining and Labeling / Q000379:methods; D014346:Trypanosoma brucei brucei / Q000187:drug effects* / Q000254:growth & development / Q000502:physiology
D000981:Antiprotozoal Agents; D034741:RNA, Small Interfering; D017382:Reactive Oxygen Species; D000255:Adenosine Triphosphate
J Clin Invest. 2004 Feb;113(4):496-504
14966556
J Mol Evol. 2005 Dec;61(6):742-57
16315106
Am J Trop Med Hyg. 2009 Oct;81(4):665-74
19815884
Mol Cell Biol. 1988 Nov;8(11):4625-33
2850466
Mol Biochem Parasitol. 2007 Jun;153(2):115-24
17397944
Anal Biochem. 2008 Nov 15;382(2):87-93
18722997
J Biol Chem. 2009 Aug 21;284(34):22512-6
19561081
Mol Biochem Parasitol. 1990 Jan 1;38(1):141-50
2157153
Autophagy. 2008 Apr;4(3):294-308
18365344
Biochem J. 1993 May 15;292 ( Pt 1):31-5
8503859
Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14177-82
12386344
J Biol Chem. 2006 Feb 10;281(6):3048-56
16316982
Eukaryot Cell. 2005 Jan;4(1):30-5
15643057
Antimicrob Agents Chemother. 2008 Mar;52(3):875-82
18086841
Trans R Soc Trop Med Hyg. 1994 May-Jun;88(3):332-3
7974681
Biochimie. 2008 Jul;90(7):999-1014
18343228
Mol Microbiol. 2008 Feb;67(4):820-9
18179422
J Cell Sci. 2006 Mar 15;119(Pt 6):1105-17
16507595
Autophagy. 2006 Apr-Jun;2(2):107-18
16874069
J Cell Sci. 1994 Jul;107 ( Pt 7):1825-32
7527048
Mol Biochem Parasitol. 2005 Jul;142(1):47-55
15907560
Mol Biochem Parasitol. 1999 Mar 15;99(1):89-101
10215027
Chem Biol Drug Des. 2006 May;67(5):355-63
16784460
J Cell Sci. 2008 Jan 1;121(Pt 1):99-109
18073240
Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17718-23
19008351
J Med Chem. 2005 Jun 2;48(11):3704-13
15916422
Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8818-21
1528898
Science. 2001 Mar 16;291(5511):2159-62
11251122
Antimicrob Agents Chemother. 2004 Mar;48(3):924-9
14982785
Mol Cell Biol. 2008 Nov;28(22):6939-53
18794366
Cell Death Differ. 2005 Apr;12(4):335-46
15678148
Int J Parasitol. 2007 Nov;37(13):1443-8
17602691
Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3726-30
7731973
Acta Trop. 1997 Nov;68(2):139-47
9386789
PLoS Negl Trop Dis. 2009 Aug 04;3(8):e495
19652702
J Biol Chem. 2004 Nov 12;279(46):48426-33
15326171
Cell Mol Life Sci. 2005 May;62(9):971-88
15761668
Mol Biochem Parasitol. 2004 Aug;136(2):249-55
15478803
Cell Death Differ. 2006 Oct;13(10):1802-14
16456581
PLoS Pathog. 2010 Jan 22;6(1):e1000731
20107599
Int J Parasitol. 2008 Mar;38(3-4):277-87
17936287
Eukaryot Cell. 2007 Aug;6(8):1439-49
17586720
EMBO J. 2001 Sep 3;20(17):4674-83
11532932
EMBO J. 2003 Oct 1;22(19):4991-5002
14517238